![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Acquisition of Sera Labs will add to CURE a growing brand portfolio and monetization platform that fits remarkably well with CURE’s development capabilities, products, and existing market verticals.
Lead Product(s): Cannabidiol,Aspartame
Therapeutic Area: Dermatology Product Name: Seratopical
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: CURE Pharmaceutical
Deal Size: $44.0 million Upfront Cash: $20.0 million
Deal Type: Acquisition July 28, 2020